NYSE:KMI
NYSE:KMIOil and Gas

Kinder Morgan (KMI): Evaluating Valuation After Q3 Revenue Growth and a Dividend Increase

Kinder Morgan (NYSE:KMI) released its third quarter results, highlighting year-over-year revenue growth along with a 2% increase in its quarterly dividend. Investors now have a fresh update on both earnings and shareholder returns. See our latest analysis for Kinder Morgan. The third quarter brought a few headlines for Kinder Morgan, including steady earnings growth and a higher dividend, along with talk of possible acquisitions. Still, the momentum has not translated into the share price...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Is Honeywell a Bargain After Recent Supply Chain Moves and Market Dip?

Wondering if Honeywell International is a bargain right now? Let's dig into what's behind the numbers and see if this industrial giant is trading for less than it's worth. Despite a steady long-term climb, Honeywell's shares have slipped in the short term, dropping 8.4% over the past week and 6.0% for the month, though they're still up 1.9% over the last year. Recent headlines have pointed to supply chain adjustments and strategic acquisitions by Honeywell, both of which have caught...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Is There Now an Opportunity in Alliance Resource Partners After Recent Energy Sector Volatility?

If you have ever wondered whether Alliance Resource Partners shares are genuinely good value or simply riding high, you are in the right place for a clear-eyed assessment. After a strong multi-year climb of more than 1000% over five years, the stock’s momentum has slowed, with a modest 1.2% gain this week but a dip of 7.5% year-to-date. Industry headlines have centered on energy market volatility and shifting attitudes toward coal stocks. Alliance Resource Partners has appeared regularly in...
NYSE:WAT
NYSE:WATLife Sciences

Waters (WAT) Net Margin Dips, Testing Bullish Profitability Narratives

Waters (WAT) reported net profit margins of 20.9%, slightly below last year’s 21.4%. Earnings have grown by 1% annually over the past five years, with EPS up 4.3% over the past year and outpacing the longer-term trend. Revenue is projected to accelerate at 12.3% per year, while earnings are expected to climb 29.4% annually. This means both are set to outpace the broader US market. See our full analysis for Waters. Next, we will see how these fresh results line up with market narratives,...
NasdaqGS:NOVT
NasdaqGS:NOVTElectronic

Novanta (NOVT): $26 Million One-Time Loss Undermines Margin Recovery Narrative

Novanta (NOVT) posted a 7.1% annual EPS growth rate over the past five years, but in the most recent year, earnings declined and net profit margins narrowed to 5.5% from 6.5% previously. The bottom line was further impacted by a one-time, $26 million loss, resulting in another layer of pressure on last year’s results. Looking forward, consensus is calling for profits to rebound sharply at 51.5% per year over the next three years, far outpacing the broader US market's 16% annual rate. However,...
NYSE:PRA
NYSE:PRAInsurance

ProAssurance (PRA): Evaluating Shareholder Returns and Current Valuation After a 52.9% Stock Surge

ProAssurance (PRA) shares have seen modest movement this week, prompting a closer look from investors interested in insurance sector trends as well as the company’s recent performance. The stock’s returns over the past year offer insight into current sentiment. See our latest analysis for ProAssurance. ProAssurance’s share price has surged 52.9% so far this year, with recent moves reflecting shifting investor expectations after a notable turnaround in performance. Its total shareholder return...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Is Alnylam Pharmaceuticals Fairly Priced After FDA Approval Drives 81.3% Rally in 2025?

Wondering if Alnylam Pharmaceuticals is actually good value right now? You are not alone, especially with all the hype and debate around biotech stocks lately. The stock has leapt an impressive 81.3% year-to-date, despite dipping 11.0% in the last week and falling 7.2% over the past month. This demonstrates both breakout growth and some recent volatility. Big moves like this have been driven by the company announcing FDA approvals for new RNAi therapies, as well as strategic partnerships...
NYSE:CXM
NYSE:CXMSoftware

Sprinklr (CXM): Evaluating Valuation After Leadership Shakeup With Karthik Suri’s Strategic Appointment

Sprinklr (CXM) has announced that Karthik Suri, with over 25 years in tech leadership, will join as Chief Product and Corporate Strategy Officer. This move could bring a fresh perspective to the company’s future direction and priorities. See our latest analysis for Sprinklr. Sprinklr’s fresh leadership comes at a moment when momentum is clearly in flux, with the stock’s share price down 11.8% year-to-date and negative over the past quarter. Still, the one-year total shareholder return of...
NasdaqGM:HLMN
NasdaqGM:HLMNMachinery

Hillman Solutions (HLMN): Margin Surge Reinforces Bullish Narratives Despite Valuation Concerns

Hillman Solutions (HLMN) reported net profit margins of 2.4%, up from last year’s 0.6%, reflecting a notable improvement in profitability. The company delivered a profit growth of 346.7% over the past year, significantly outpacing its five-year average of 57.2% per year. It has now maintained profitable results for several consecutive years. With forecasts pointing to annual earnings growth of 30.3%, investors are weighing the potential for continued momentum against persistent concerns about...
NYSE:FIX
NYSE:FIXConstruction

How Investors May Respond To Comfort Systems USA (FIX) Dividend Hike and Strong Third Quarter Results

In October 2025, Comfort Systems USA announced third quarter results with strong year-over-year growth in both revenue (rising to US$2.45 billion) and net income, while also increasing its quarterly dividend by US$0.10 to US$0.60 per share and updating on its ongoing share buyback program. Alongside robust earnings and a record backlog reported, the company’s board-approved dividend increase underscores management’s confidence in long-term cash flow and future performance. We’ll explore how...
NYSE:MLM
NYSE:MLMBasic Materials

Profit Margin Drop at Martin Marietta (MLM) Challenges Bullish Narratives on Resilience

Martin Marietta Materials (MLM) posted a net profit margin of 17.2%, down from last year’s 30.5%, highlighting a notable decline in profitability. The results include a substantial one-off gain of $1.3 billion, impacting the latest figures. Earnings have grown at an average annual rate of 19.6% over the past five years. Looking ahead, analysts forecast earnings growth of 10.6% per year and revenue growth of 6.9% per year, both lagging the broader US market outlook. The current...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Strong 2025 Revenue and Earnings Outlook Might Change the Case for Investing in Medpace Holdings (MEDP)

Medpace Holdings recently reported third-quarter results showing year-over-year increases in revenue (US$659.9 million) and net income (US$111.14 million), and issued 2025 guidance projecting full-year revenue between US$2.48 billion and US$2.53 billion and GAAP net income between US$431 million and US$439 million. This outlook highlights continued growth momentum and points to Medpace’s confidence in strong industry demand and operational execution, with revenue guidance implying very large...
NYSE:HUM
NYSE:HUMHealthcare

Is Humana Still Attractive After Recent Share Price Volatility and Regulatory Headlines?

Curious if Humana stock is a bargain or overhyped? Let’s dig into what’s really driving its value, beyond the surface numbers. The share price has moved noticeably, rising 11.6% year-to-date and nearly 10% over the past year. However, short-term dips like last week's drop of 4.4% show sentiment can still swing fast. Recent headlines about regulatory updates in managed care and changes in Medicare reimbursement rates have brought fresh volatility to the sector. Industry analysts are also...
NYSE:VAL
NYSE:VALEnergy Services

Did Valaris' (VAL) Higher Earnings and Share Buybacks Outshine Its Declining Revenue?

Valaris Limited reported its third quarter 2025 results, with net income rising to US$188.1 million despite sales declining to US$595.7 million, and announced it had completed the repurchase of 9.35% of its shares since 2022. This combination of higher earnings and substantial share repurchases stands out at a time when the company saw lower year-over-year revenue. We’ll explore how the significant increase in net income amid ongoing share buybacks could influence Valaris’s investment...
NYSE:ELME
NYSE:ELMEResidential REITs

Elme Communities (ELME): Valuation Revisited After Net Loss and Real Estate Impairment Charge

Elme Communities (NYSE:ELME) just posted its third quarter results, revealing a significant net loss along with a large real estate impairment charge. Both announcements highlight real financial pressure for shareholders at this time. See our latest analysis for Elme Communities. After its quarterly update showing a significant net loss and real estate impairment, Elme Communities’ stock has shown some resilience, holding a 9.6% year-to-date share price return despite these challenges...
NYSE:PRKS
NYSE:PRKSHospitality

A Look at United Parks & Resorts (PRKS) Valuation Following CFO Transition Announcement

United Parks & Resorts (PRKS) recently announced that James Mikolaichik will step down as Chief Financial Officer and Treasurer on November 15, 2025. Senior finance executive Jim Forrester will assume both roles on an interim basis. See our latest analysis for United Parks & Resorts. The leadership changes at United Parks & Resorts shook up the market, with the one-week share price return sliding 10.2%, as investors digested the news of the long-serving CFO departing. Over the past year,...
NasdaqGS:PAA
NasdaqGS:PAAOil and Gas

Assessing Plains All American Pipeline Shares After Midstream Infrastructure News and a 5% Price Dip

Ever wondered if Plains All American Pipeline stock could be a hidden gem or if you might be chasing it past its prime? You're not alone, and looking at current value is more important than ever. While shares are up a solid 220.0% over the past five years, this year has seen a -5.1% dip so far, with short-term returns also trending lower. Much of the recent share price movement has been driven by industry buzz around infrastructure upgrades and changes in energy demand, with several notable...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

UFP Technologies (UFPT) Margin Decline Reinforces Cautious Sentiment on Growth Outlook

UFP Technologies (UFPT) reported net profit margins of 11.2%, down from 11.7% a year ago, with recent annual earnings growth of 23.8% underperforming its five-year average of 31.6%. Looking ahead, earnings are forecast to rise at 14.33% per year and revenue growth is expected at 5.6% annually, which trails the broader US market’s 10.5% projected pace. While the company's Price-to-Earnings Ratio of 25.6x sits below the US Medical Equipment industry average but above its peer group, shares are...
NYSE:KW
NYSE:KWReal Estate

Kennedy-Wilson Stock Drops 25% in 2024 Amid Real Estate Volatility, Is Opportunity Emerging?

Wondering if Kennedy-Wilson Holdings is now a value play or if there is more trouble ahead? Let’s dive in and see whether curiosity is rewarded. The stock has tumbled in 2024, dropping 24.7% year-to-date and losing over 28% across the last twelve months as investor sentiment has shifted quickly. Recent headlines have centered on industry-wide volatility in real estate, with rising interest rates and macro uncertainty putting pressure on REITs and property holding firms like Kennedy-Wilson...
NasdaqGS:EXPO
NasdaqGS:EXPOProfessional Services

A Fresh Look at Exponent (EXPO) Valuation After Strong Earnings and $100M Share Buyback Expansion

Exponent (EXPO) caught market attention after it posted higher revenue and net income for the recent quarter. The company also announced a $100 million boost to its share repurchase program and reaffirmed its dividend. See our latest analysis for Exponent. Although Exponent’s extra buyback firepower and stable dividend have provided a recent boost to sentiment, momentum is still building after a tough year. The stock has climbed 6.9% over the past month as investors warmed to improving...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

Does DraftKings’ Recent 21.5% Drop Signal a Hidden Opportunity in 2025?

Ever wondered if DraftKings is a bargain right now, or if you’ve missed your shot? Let’s dig into the numbers and see if there’s real value hiding behind the buzz. Despite some rollercoaster moments, DraftKings has dropped 21.5% over the last year and is down even more over the past month. Look closer and you’ll spot a massive 128.0% gain over three years, which signals that growth questions are still on the table. Recently, the stock has been moving in response to broader trends in online...
NYSE:QGEN
NYSE:QGENLife Sciences

What Do Recent Product Launches Mean for Qiagen’s Valuation in 2025?

Wondering if Qiagen is a smart buy right now? You are not alone, as there has been a lot of chatter lately about whether the current share price offers real value to investors. The stock has dipped 7.9% in the past week and 5.6% over the last month, with a somewhat muted 3.6% decline year-to-date. However, it has managed to eke out a modest 1.0% gain over the past year. Qiagen has caught attention recently with its ongoing innovations in biotech solutions and a series of new product...
NYSE:HLT
NYSE:HLTHospitality

How Strong Q3 Results and Raised Guidance at Hilton (HLT) Have Changed Its Investment Story

In October 2025, Hilton Worldwide Holdings Inc. announced strong third quarter results, affirming a quarterly dividend of US$0.15 per share, updating share buyback progress, and raising both fourth quarter and full-year earnings guidance. An important insight is that Hilton reported meaningful year-over-year increases in revenue and net income, while also highlighting continued share repurchases totaling US$12.16 billion since 2017. We'll explore how Hilton's improved earnings guidance and...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Radware (RDWR): Assessing Valuation After Strong Q3 Results and Upbeat Revenue Outlook

Radware (NasdaqGS:RDWR) posted higher third quarter revenue and net income compared to last year, and management just announced guidance calling for continued revenue growth in the upcoming period. See our latest analysis for Radware. After a solid run through the year, Radware’s momentum cooled this month, with a 1-day share price return of -4.4% and a 7-day drop of -10.7% following strong third quarter earnings and upbeat guidance. Even so, its 1-year total shareholder return of 6.3%...